Evidence map›Paper›PMID 41647650›Full record

ArticleOsteoarthritis and cartilage open2026

Investigating predictors of pain events during trials of knee osteoarthritis: A post-hoc analysis of two phase III trials.

Andrea Bak Kaaber, Jakob Mejdahl Bentin, Ida Sofie Adrian, Morten Asser Karsdal, Asger Reinstrup Bihlet

Abstract read
In one paragraph

Article in Osteoarthritis and cartilage open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrea Bak KaaberNBCD A/S, Denmark.
Jakob Mejdahl BentinNBCD A/S, Denmark.
Ida Sofie AdrianNBCD A/S, Denmark.
Morten Asser KarsdalNordic Bioscience A/S, Denmark.
Asger Reinstrup BihletNBCD A/S, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aims to explore the associations between clinical characteristics, including medical history, and the frequency, severity, and type of pain events (PEs) over a two-year period in patients with knee osteoarthritis (OA). Design: A post-hoc analysis was conducted on data from two double-blinded, randomized, placebo-controlled, multicenter phase-III trials assessing the efficacy and safety of salmon calcitonin in patients with painful and radiographic knee OA. 2206 patients aged 51-80 years were included. Adverse events (AEs) were recorded and categorized into PEs and non-PEs. Logistic regression models were used to assess associations, adjusting for confounders such as age, sex, and body mass index (BMI). Results: Of the 8183 AEs recorded, 27.6 % were classified as PEs. Higher BMI was associated with lower odds of reporting PEs (OR: 0.94, p = 0.02), while male patients reported fewer PEs than females (OR: 0.83, p = 0.04). Insomnia and depression were linked to increased odds of PEs. In the PE population, higher BMI was associated with increased odds of moderate and severe PEs. KL grade 3 was linked to lower odds of moderate and severe PEs. Conclusions: The study identifies female sex and certain medical histories as significant predictors of PEs in knee OA patients. A higher BMI was associated with lower odds of reporting PEs but for those who reported PEs, higher BMI was associated with more severe PEs. These results should be interpreted with caution due to methodological limitations, however the findings indicate risk factors for pain events and suggest further research into these associations.

Indexed as

KneeObesityOsteoarthritisPainRandomized controlled trials

Identifiers

PMID41647650
PMCPMC12870780

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.